ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 26 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
Q2 2017 | $4,000 | +33.3% | 500 | 0.0% | 0.00% | – |
Q1 2017 | $3,000 | -75.0% | 500 | -75.0% | 0.00% | – |
Q4 2016 | $12,000 | -20.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2016 | $15,000 | -11.8% | 2,000 | 0.0% | 0.00% | – |
Q2 2016 | $17,000 | +30.8% | 2,000 | 0.0% | 0.00% | – |
Q1 2016 | $13,000 | -23.5% | 2,000 | 0.0% | 0.00% | – |
Q4 2015 | $17,000 | +240.0% | 2,000 | +100.0% | 0.00% | – |
Q3 2015 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | – |
Q2 2015 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2015 | $6,000 | +100.0% | 1,000 | +171.0% | 0.00% | – |
Q3 2014 | $3,000 | – | 369 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |